Evidence map›Paper›PMID 38238959›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Epidemiological characteristics of familiar adult inherited metabolic liver disease].

C Liang, L Bai, Z P Duan, S J Zheng

Open access · greenAbstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. [Inherited metabolic liver disease causing copper deposition].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

C LiangFirst Department of Liver Disease, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China.
L BaiBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China Fourth Department of Liver Disease, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Z P DuanBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China Fourth Department of Liver Disease, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
S J ZhengFirst Department of Liver Disease, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Beijing YouAn Hospital · CN

Funding

Beijing Hospital Management Center Key Medical Professional Development Plan ZYLX202125Beijing Natural Science Foundation 7202068, 7222093Beijing Science and Technology New Star program cross-cooperation project 20230484455Capital Health Development Scientific Research Project 2022-1-2182High-level public health technical talents of Beijing Municipal Health Commission Academic Leader -02-14
6 · The paper itself

Abstract

Inherited metabolic liver diseases can occur in multi-age groups such as children, adolescents, adults, and others. With the improvement of diagnosis and treatment levels, more and more patients with childhood-onset diseases are surviving into adulthood. Some diseases originally faced by pediatric hepatologists also appear in adult hepatology clinics. This raises new challenges for adult hepatologists, requiring them to master more professional knowledge. However, specific data on the incidence rate of most inherited metabolic liver diseases is still lacking in our country. This article reviews the research progress of hereditary metabolic liver diseases and summarizes the epidemiological characteristics of familiar hereditary metabolic liver diseases in China.

Indexed as

Liver DiseasesLiver TransplantationMetabolic DiseasesAdolescentAdultChildHumansIncidenceAdultEpidemiologyInherited metabolic liver diseaseMorbidity

Identifiers

PMID38238959
PMCPMC12814645
OpenAlexW4391036225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.